| Full Name | Thomas Dohlman |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 13 Years |
| Location | 243 Charles St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174938120 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 274470 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Massachusetts Eye And Ear Infirmary - | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts Eye And Ear Associates, Inc | 4486540275 | 337 |
| Childrens Hospital Ophthalmology Foundation Inc | 8729049150 | 20 |
News Archive
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the search for an improved method of treating atrial fibrillation (AF) will be unaffected by the recent mixed decision by the Food and Drug Administration (FDA) panel on Medtronic's phased radiofrequency (RF) pulmonary vein ablation catheter (PVAC).
Giving severely depressed patients the arthritis drug celecoxib (Celebrex) dramatically boosted the effectiveness of their antidepressant medication, a Loyola study has found.
Economist says half of the rural poor who would be aided by expansion live in states that have opted not to take that step.
Small cell lung cancer (SCLC) is an aggressive disease that is difficult to treat and is frequently only diagnosed when it has spread to other parts of the body (metastasised). Five-year survival rates in SCLC, which accounts for about 14% of all lung cancers, are very low, at only six percent. But today US researchers will present two novel findings with important implications for treatment at the 2015 European Cancer Congress.
› Verified 8 days ago
| Entity Name | Massachusetts Eye And Ear Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932574332 PECOS PAC ID: 4486540275 Enrollment ID: O20040227000123 |
News Archive
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the search for an improved method of treating atrial fibrillation (AF) will be unaffected by the recent mixed decision by the Food and Drug Administration (FDA) panel on Medtronic's phased radiofrequency (RF) pulmonary vein ablation catheter (PVAC).
Giving severely depressed patients the arthritis drug celecoxib (Celebrex) dramatically boosted the effectiveness of their antidepressant medication, a Loyola study has found.
Economist says half of the rural poor who would be aided by expansion live in states that have opted not to take that step.
Small cell lung cancer (SCLC) is an aggressive disease that is difficult to treat and is frequently only diagnosed when it has spread to other parts of the body (metastasised). Five-year survival rates in SCLC, which accounts for about 14% of all lung cancers, are very low, at only six percent. But today US researchers will present two novel findings with important implications for treatment at the 2015 European Cancer Congress.
› Verified 8 days ago
| Entity Name | Childrens Hospital Ophthalmology Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770679045 PECOS PAC ID: 8729049150 Enrollment ID: O20041020000189 |
News Archive
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the search for an improved method of treating atrial fibrillation (AF) will be unaffected by the recent mixed decision by the Food and Drug Administration (FDA) panel on Medtronic's phased radiofrequency (RF) pulmonary vein ablation catheter (PVAC).
Giving severely depressed patients the arthritis drug celecoxib (Celebrex) dramatically boosted the effectiveness of their antidepressant medication, a Loyola study has found.
Economist says half of the rural poor who would be aided by expansion live in states that have opted not to take that step.
Small cell lung cancer (SCLC) is an aggressive disease that is difficult to treat and is frequently only diagnosed when it has spread to other parts of the body (metastasised). Five-year survival rates in SCLC, which accounts for about 14% of all lung cancers, are very low, at only six percent. But today US researchers will present two novel findings with important implications for treatment at the 2015 European Cancer Congress.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Dohlman, MD 243 Charles St, Boston, MA 02114-3002 Ph: (617) 573-4443 | Thomas Dohlman, MD 243 Charles St, Boston, MA 02114 Ph: (617) 573-4443 |
News Archive
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the search for an improved method of treating atrial fibrillation (AF) will be unaffected by the recent mixed decision by the Food and Drug Administration (FDA) panel on Medtronic's phased radiofrequency (RF) pulmonary vein ablation catheter (PVAC).
Giving severely depressed patients the arthritis drug celecoxib (Celebrex) dramatically boosted the effectiveness of their antidepressant medication, a Loyola study has found.
Economist says half of the rural poor who would be aided by expansion live in states that have opted not to take that step.
Small cell lung cancer (SCLC) is an aggressive disease that is difficult to treat and is frequently only diagnosed when it has spread to other parts of the body (metastasised). Five-year survival rates in SCLC, which accounts for about 14% of all lung cancers, are very low, at only six percent. But today US researchers will present two novel findings with important implications for treatment at the 2015 European Cancer Congress.
› Verified 8 days ago
Dr. Maan Sulaiman A Alkharashi, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Fegan 4, Boston, MA 02115 Phone: 857-523-6040 | |
Daniel J Townsend, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 175 Cambridge St, C/o Prooptical, Boston, MA 02114 Phone: 617-723-3937 Fax: 617-523-5006 | |
Daniel Robert Lefebvre, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, 10th Floor -- Ophthalmic Plastic Surgery, Boston, MA 02114 Phone: 617-523-7900 | |
Dr. Seanna Rae Grob, MD, MAS Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-523-7900 | |
Ravi Parikh, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3288 | |
Michael V Boland, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3611 | |
Dr. Parvathy A Pillai, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-647-1226 Fax: 617-573-3181 |